OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-4760417
  • Global Advanced Visualization Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: March 2017 | Report Code: HHE-4760417

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

The global advanced visualization market is estimated to have the CAGR of 11% during the forecast period 2016-2023.The advanced visualization platform allows clinicians to facilitate advanced diagnosis in an effective and accurate manner. Visualization method helps the clinicians to access and share large sets of images. Advanced visualization software is highly used in imaging modalities to interpret workflow of magnetic resonance imaging and computed tomography. The key trend influencing the market is continues advancement with multispecialty clinical applications. For example, the new upgraded cardiac MRI visualization and quantification software which automates the various processes involved. Moreover, it uses a cloud-based platform that enables access to a large amount of computing power required to process cardiac cine functional data in real time manner. Factors driving the global advanced visualization market are as follows:

  • Technological advancements
  • Increasing use of advanced visualization technique in hospitals
  • Increasing cases of cancer and CVD across the globe
  • Increasing focus among healthcare organizations to increase workflow efficiency





The key factor driving the growth of global advanced visualization market is the increasing cases of cancer & CVD across the globe. In 2016, an estimated 1,685,210 new cases of cancer were diagnosed in United States and 595,690 people died from it. Cancer is the second major cause of death worldwide, and it was responsible for approx. 8.8 million deaths in 2015. Nearly 1 in 6 deaths happened due to cancer globally. Nearly 70% of deaths from cancer happen in low- and middle-income countries. Using tobacco is the most significant risk factor for cancer and it is responsible for nearly 22% of deaths. Cancer also causes infections i.e. human papilloma virus (HPV) and hepatitis which is responsible for over 25% of cancer incidences in low and middle income countries. In 2015, only 36% of low-income countries reported taking pathology services usually offered in the public sector. Over 90% of high-income countries stated treatment services are accessible compared to lower than 30% of low-income countries. The major causes of cancer death in 2015 were from Lungs (approx.1.69 million deaths), Liver (approx.788 000 deaths), Colorectal (approx. 774 000 deaths), Stomach (approx.754 000 deaths) and Breast (approx.571 000 deaths). Likewise, cases of cardiovascular diseases are also increasing across the globe. Cardiovascular disease is also a prime cause of death which accounts for approximately 801,000 deaths in the United States that is approx. 1 of each 3 deaths in the country. Approx. 2,200 Americans died from cardiovascular disease every day. Approx. 92.1 million American adults are suffering with some type of cardiovascular disease or after-effects of stroke. Thus, growing prevalence of such diseases leads the demand for advanced techniques in healthcare sector for early and accurate diagnosis which is boosting advanced visualization market. Due to such contributing factors, the market is expected to grow with the CAGR of approximately 11.4% during the forecast period. However, technical complexities and high cost of AV tools are some factors hindering the market growth. The market has huge scope with the growing medical tourism across the globe and increasing healthcare expenditure in developing countries. The market is facing some challenges such as high initial investment and lack of skilled professionals.

Source: OBRC Analysis

The global advanced visualization market has been segmented on the basis of type of platform, application and end user. According to type of platform, the market is further segmented into:

  • Computed Tomography
  • Ultrasound
  • Positron Emission Tomography (PET)
  • Radiotherapy (RT)
  • Magnetic resonance imaging (MRI)
  • Others







Applications is further segmented into:

  • Neurology
  • Oncology
  • Cardiology
  • Orthopedics
  • Other application






End –user is further segmented into:

  • Academic & research centers
  • Imaging centers
  • Hospitals & surgical centers
  • Others





The revenue for the above clinical application and end-user are specific to the advanced visualization market. However, the total revenue of these application and end-userin general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up platform and applications.

Geographically, the global advanced visualization market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





 North America occupied the major share in the global advanced visualization market in 2015 due to the better healthcare infrastructure in the region, high patient awareness, strong economy, and easy accessibility for advanced technology. Rapid growth in geriatric population is also another major driving factor for the market. As per the U.S. Census Bureau, approx. 19% of the population in the region will be over 65 years of age by 2030. Europe has also witnessed a rapid growth owing to growing healthcare expenditure along with efforts to augment such expenditures with the use of novel medical techniques. Asia Pacific has also shown growth rate for the market in countries such as India and China. Large population base coupled with rising medical tourism in the region is primarily supporting the market demand. Moreover, increasing focus to create better healthcare infrastructure as well as focus on the R&D in the healthcare sector is also enhancing the market growth in the region.

The global advanced visualization market is segmented on the basis of type of platform, application and end user.. According to type of platform, the market is further segmented into computed tomography, ultrasound, positron emission tomography (PET), Radiotherapy (RT), Magnetic resonance imaging (MRI) and others. Among type of platform, CT (computed tomography) was accounted for major share owing to high popularity of such imaging test in diagnostic centers. According to application, the market is further segmented into neurology, oncology, cardiology, orthopedics and other applications. Oncology is one of the major application segments owing to rapid growth in cancer cases globally. According to end user, the market is further segmented into academic & research centers, imaging centers, hospitals & surgical centers and other end users. Hospitals & surgical centers are one of the major users of such systems for accurate and precise images which supports for better interpretation of results.

 The major market players of the global advanced visualization market are:

  • GE HEALTHCARE
  • CARESTREAM HEALTH
  • PHILIPS
  • SIEMENS AG
  • VITAL IMAGES
  • OTHERS







Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis. 

These companies use various strategies such as mergers & acquisition, product launches etc. to expand market share and gain competitive advantage. For example: In June 2016, Vital launched Vitrea® 7, a latest Era in Advanced Visualization. Such innovative, application-based platform offers full-powered systems for 2D, 3D and 4D medical imaging as well as comprehensive user workflows, comprising MR, CT and XA applications. Similarly, Siemens introduced the Artis pheno angiography system in 2016. It removed most of the cabling used in previous Siemens systems and not even requires a ceiling mount. It uses a large robotic arm to articulate around patients on almost any axis.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as product launch ason June 2016, Vital launched Vitrea® 7, a latest Era in Advanced Visualization
  • Provide in detail the different segments such as platform, application and end-users which affect the global advanced visualization market.
  • Provide you the patent analysis of global advanced visualization market.
  • Identify and understand the strengths, opportunities, challenges and threat of the smart security market.
  • Provide revenues of major players of the market such as Hitachi, care stream health and Ge healthcare
  • Provide you the various regulatory policies which affect the global advanced visualization market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global smart security market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global advanced visualization market such asContinues Advancement with multispecialty clinical applications and technological upgradation in the imaging modalities system. For each market segments covered in global advanced visualization market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the advancedvisualization industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global advanced visualization market:

  • North America had the largest revenue share in 2016.
  • CT (computed tomography) segment is dominating the market due to high popularity of such imaging test in diagnostic centers.
  • Hospitals & surgical centers are one of the major users of such systems as it ensures accurate and precise images which helps in better interpretation of result.
  • Product launch is the key strategy adopted by the various market players of global advanced visualization market.
  • Oncology is the major application segments owing to rapid growth in cancer cases globally.
1.   INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2.       MARKET OVERVIEW
2.1. GLOBAL ADVANCED VISUALIZATION MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIs
2.5.1.        TOP 5 FINDINGS
2.5.2.        TOP 5 OPPORTUNITY MARKETS
2.5.3.        TOP 5 COMPANIES
2.5.4.        TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1.        INVESTMENT VS. ADOPTION MODEL
2.7.2.        360 DEGREE INDUSTRY ANALYSIS
2.7.3.        PORTERS 5 FORCE MODEL
2.7.4.        SEE-SAW ANALYSIS
2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1.        KEY STRATEGIES & ANALYSIS
2.8.2.        MARKET SHARE  &TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3.       MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1.        TECHNOLOGICAL ADVANCEMENTS
3.1.2.        PREVALENCE OF CANCER AND CVD ACROSS THE GLOBE
3.1.3.        GROWING ADOPTION AMONG HOSPITALS
3.1.4.        GROWING FOCUS AMONG HEALTHCARE ORGANIZATIONS TO INCREASE WORKFLOW EFFICIENCY
3.2. MARKET RESTRAINTS
3.2.1.        TECHNICAL COMPLEXITIES
3.2.2.        HIGH COST OF AV TOOLS
3.3. MARKET OPPORTUNITIES
3.3.1.        GROWING MEDICAL TOURISM ACROSS THE GLOBE
3.3.2.        INCREASING HEALTHCARE EXPENDITURE IN DEVELOPING COUNTRIES
3.4.   MARKET CHALLENGES
3.4.1.        HIGH INITIAL INVESTMENT
3.4.2.        LACK OF SKILLED PROFESSIONALS
 
4.       MARKET SEGMENTATION
4.1.                    GLOBAL ADVANCED VISUALIZATION MARKET BY TYPE OF PLATFORM 2014-2023 ($ MILLION)
4.1.1.        MARKET DEFINITION AND SCOPE
4.1.2.        DECISION SUPPORT 
4.1.3               DATABASE & ESTIMATION METHODOLOGY
4.1.4.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.5.        OPPORTUNITY MATRIX
4.1.6.        MARKET SEGMENTATION BY TYPE OF PLATFORM 2014-2023 ($ MILLION) 
4.1.6.1.                      GLOBAL ADVANCED VISUALIZATION MARKET BY COMPUTED TOMOGRAPHY (CT) 2014-2023 ($ MILLION)
4.1.6.1.1.    APPLICATION
4.1.6.1.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.1.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.1.4.         TOP PLAYERS & KEY PRODUCTS
4.1.6.1.5.         REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.6.1.6.         KEY CONCLUSIONS
4.1.5.2.                      GLOBAL ADVANCED VISUALIZATION MARKET BY ULTRASOUND 2014-2023 ($ MILLION)
4.1.5.2.1.    APPLICATION
4.1.5.2.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4.         TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5.         REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.2.6.         KEY CONCLUSIONS
4.1.5.3.                      GLOBAL ADVANCED VISUALIZATION MARKET BY POSITRON EMISSION TOMOGRAPHY (PET) 2014-2023 ($ MILLION)
4.1.5.3.1.         APPLICATION
4.1.5.3.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4.         TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5.         REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.3.6.         KEY CONCLUSIONS
4.1.5.4.                      GLOBAL ADVANCED VISUALIZATION MARKET BY RADIOTHERAPY (RT) 2014-2023 ($ MILLION)
4.1.5.4.1.    APPLICATION
4.1.5.4.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.4.         TOP PLAYERS & KEY PRODUCTS
4.1.5.4.5.         REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.4.6.         KEY CONCLUSIONS
4.1.5.5.                      GLOBAL ADVANCED VISUALIZATION MARKET BY MAGNETIC RESONANCE IMAGING (MRI) 2014-2023 ($ MILLION)
4.1.5.6.                      APPLICATION
4.1.5.6.1.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.6.3.         TOP PLAYERS & KEY PRODUCTS
4.1.5.6.4.         REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.6.5.         KEY CONCLUSIONS
4.1.5.7.                      GLOBAL ADVANCED VISUALIZATION MARKET BY OTHERS 2014-2023 ($ MILLION)
4.1.5.7.1.    APPLICATION
4.1.5.7.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.7.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.7.4.         TOP PLAYERS & KEY PRODUCTS
4.1.5.7.5.         REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.7.6.         KEY CONCLUSIONS
4.2.                    GLOBAL ADVANCED VISUALIZATION MARKET BY APPLICATION 2014-2023 ($ MILLION)
4.2.1.        MARKET DEFINITION AND SCOPE
4.2.2.        DECISION SUPPORT 
4.2.3DATABASE & ESTIMATION METHODOLOGY
4.2.4.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.5.         OPPORTUNITY MATRIX
4.2.6.        MARKET SEGMENTATION BY APPLICATION 2014-2023 ($ MILLION) 
4.2.6.1.                      GLOBAL ADVANCED VISUALIZATION MARKET BY NEUROLOGY 2014-2023 ($ MILLION)
4.2.6.1.1.         APPLICATION
4.2.6.1.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.6.1.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.6.1.4.         TOP PLAYERS & KEY PRODUCTS
4.2.6.1.6.         KEY CONCLUSIONS
4.2.5.2.                      GLOBAL ADVANCED VISUALIZATION MARKET BY ONCOLOGY 2014-2023 ($ MILLION)
4.2.5.2.1.    APPLICATION
4.2.5.2.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4.         TOP PLAYERS & KEY PRODUCTS
4.2.5.2.6.         KEY CONCLUSIONS
4.2.5.3.                      GLOBAL ADVANCED VISUALIZATION MARKET BY CARDIOLOGY 2014-2023 ($ MILLION)
4.2.5.3.1.    APPLICATION
4.2.5.3.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4.         TOP PLAYERS & KEY PRODUCTS
4.2.5.3.6.         KEY CONCLUSIONS
4.2.5.4.                      GLOBAL ADVANCED VISUALIZATION MARKET BY ORTHOPEDICS 2014-2023 ($ MILLION)
4.2.5.4.1.    APPLICATION
4.2.5.4.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4.         TOP PLAYERS & KEY PRODUCTS
4.2.5.4.6.         KEY CONCLUSIONS
4.2.5.5.                      GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER APPLICATIONS 2014-2023 ($ MILLION)
4.2.5.6.                      APPLICATION
4.2.5.6.1.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.6.3.         TOP PLAYERS & KEY PRODUCTS
4.2.5.6.5.         KEY CONCLUSIONS
4.3.                    GLOBAL ADVANCED VISUALIZATION MARKET BY END USER 2014-2023 ($ MILLION)
4.3.1.        MARKET DEFINITION AND SCOPE
4.3.2.        DECISION SUPPORT 
4.3.3                 DATABASE & ESTIMATION METHODOLOGY
4.3.4.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.5.         OPPORTUNITY MATRIX
4.3.6.        MARKET SEGMENTATION BY END USER 2014-2023 ($ MILLION) 
4.3.6.1.                      GLOBAL ADVANCED VISUALIZATION MARKET BY ACADEMIC & RESEARCH CENTERS 2014-2023 ($ MILLION
4.3.6.1.1.    APPLICATION
4.3.6.1.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.6.1.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.6.1.4.         TOP PLAYERS & KEY PRODUCTS
4.3.6.1.5.         REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.6.1.6.         KEY CONCLUSIONS
4.3.5.2.                      GLOBAL ADVANCED VISUALIZATION MARKET BY IMAGING CENTERS 2014-2023 ($ MILLION)
4.3.5.2.1.    APPLICATION
4.3.5.2.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4.         TOP PLAYERS & KEY PRODUCTS
4.3.5.2.6.         KEY CONCLUSIONS
4.3.5.3.                      GLOBAL ADVANCED VISUALIZATION MARKET BY HOSPITALS & SURGICAL CENTERS 2014-2023 ($ MILLION)
4.3.5.3.1.    APPLICATION
4.3.5.3.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4.         TOP PLAYERS & KEY PRODUCTS
4.3.5.3.6.         KEY CONCLUSIONS
4.3.5.4.                      GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER END USERS 2014-2023 ($ MILLION)
4.3.5.4.1.    APPLICATION
4.3.5.4.2.         ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.4.         TOP PLAYERS & KEY PRODUCTS
4.3.5.4.6.         KEY CONCLUSIONS
 
5.       COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1.        LIST OF M&A
5.1.2.        LIST OF JV
5.1.3.        LIST OF PRODUCT LAUNCHES
5.1.4.        LIST OF PARTNERSHIP
 
6.       GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4.                     GLOBAL ADVANCED VISUALIZATION MARKET BY REGION 2014-2023 ($ MILLION) 
6.4.1.     NORTH AMERICA
6.4.1.1.  INDUSTRIAL APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2.  TOP COUNTRY ANALYSIS
6.4.1.2.1.    U.S. 
6.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2.   TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3.   KEY CONCLUSIONS
6.4.1.2.2.    CANADA
6.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2.   TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3.   KEY CONCLUSIONS
6.4.2.     EUROPE
6.4.2.1.  INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2.  TOP COUNTRY ANALYSIS
6.4.2.2.1.    UK
6.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2.   TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3.   KEY CONCLUSIONS
6.4.2.2.2.    FRANCE
6.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2.   TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3.   KEY CONCLUSIONS
6.4.2.2.3.    GERMANY
6.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2.   TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3.   KEY CONCLUSIONS
6.4.2.2.4.    SPAIN
6.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2.   TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3.   KEY CONCLUSIONS
6.4.2.2.5.    REST OF EUROPE
6.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2.   TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3.   KEY CONCLUSIONS
6.4.3.     ASIA PACIFIC
6.4.3.1.  INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2.  TOP COUNTRY ANALYSIS
6.4.3.2.1.    CHINA
6.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2.   TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3.   KEY CONCLUSIONS
6.4.3.2.2.    INDIA
6.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2.   TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3.   KEY CONCLUSIONS
6.4.3.2.3.    JAPAN
6.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2.   TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3.   KEY CONCLUSIONS
6.4.3.2.4.    AUSTRALIA
6.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2.   TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3.   KEY CONCLUSIONS
6.4.3.2.5.    REST OF ASIA PACIFIC
6.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2.   TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3.   KEY CONCLUSIONS
6.4.4.     ROW
6.4.4.1.  INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2.  TOP COUNTRY ANALYSIS
6.4.4.2.1.    LATIN AMERICA
6.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2.   TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3.   KEY CONCLUSIONS
6.4.4.2.2.    MIDDLE EAST & AFRICA 
6.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2.   TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3.   KEY CONCLUSIONS
 
7.       COMPANY PROFILES
7.1. CARESTREAM HEALTH INC.
7.1.1.        OVERVIEW
7.1.2.        PRODUCT PORTFOLIO
7.1.3.        KEY INNOVATION SECTOR
7.1.4.        STRATEGIC INITIATIVES
7.1.5.        SCOT ANALYSIS
7.1.6.        STRATEGIC ANALYSIS
7.2. CONMED CORPORATION
7.2.1.        OVERVIEW
7.2.2.        PRODUCT PORTFOLIO
7.2.3.        KEY INNOVATION SECTOR
7.2.4.        STRATEGIC INITIATIVES
7.2.5.        SCOT ANALYSIS
7.2.6.        STRATEGIC ANALYSIS
7.3. FUJIFILM HOLDINGS CORPORATION
7.3.1.        OVERVIEW
7.3.2.        PRODUCT PORTFOLIO
7.3.3.        KEY INNOVATION SECTOR
7.3.4.        STRATEGIC INITIATIVES
7.3.5.        SCOT ANALYSIS
7.3.6.        STRATEGIC ANALYSIS
7.4. GE HEALTHCARE
7.4.1.        OVERVIEW
7.4.2.        PRODUCT PORTFOLIO
7.4.3.        KEY INNOVATION SECTOR
7.4.4.        STRATEGIC INITIATIVES
7.4.5.        SCOT ANALYSIS
7.4.6.        STRATEGIC ANALYSIS
7.5. HITACHI
7.5.1.        OVERVIEW
7.5.2.        PRODUCT PORTFOLIO
7.5.3.        KEY INNOVATION SECTOR
7.5.4.        STRATEGIC INITIATIVES
7.5.5.        SCOT ANALYSIS
7.5.6.        STRATEGIC ANALYSIS
7.6. MCKESSON CORPORATION
7.6.1.        OVERVIEW
7.6.2.        PRODUCT PORTFOLIO
7.6.3.        KEY INNOVATION SECTOR
7.6.4.        STRATEGIC INITIATIVES
7.6.5.        SCOT ANALYSIS
7.6.6.        STRATEGIC ANALYSIS
7.7. NOVARAD
7.7.1.        OVERVIEW
7.7.2.        PRODUCT PORTFOLIO
7.7.3.        KEY INNOVATION SECTOR
7.7.4.        STRATEGIC INITIATIVES
7.7.5.        SCOT ANALYSIS
7.7.6.        STRATEGIC ANALYSIS
7.8. PHILIPS NV
7.8.1.        OVERVIEW
7.8.2.        PRODUCT PORTFOLIO
7.8.3.        KEY INNOVATION SECTOR
7.8.4.        STRATEGIC INITIATIVES
7.8.5.        SCOT ANALYSIS
7.8.6.        STRATEGIC ANALYSIS
7.9. PRO MEDICUS
7.9.1.        OVERVIEW
7.9.2.        PRODUCT PORTFOLIO
7.9.3.        KEY INNOVATION SECTOR
7.9.4.        STRATEGIC INITIATIVES
7.9.5.        SCOT ANALYSIS
7.9.6.        STRATEGIC ANALYSIS
7.10.QI IMAGING
7.10.1.    OVERVIEW
7.10.2.    PRODUCT PORTFOLIO
7.10.3.    KEY INNOVATION SECTOR
7.10.4.    STRATEGIC INITIATIVES
7.10.5.    SCOT ANALYSIS
7.10.6.    STRATEGIC ANALYSIS
7.11.RAMSOFT
7.11.1.    OVERVIEW
7.11.2.    PRODUCT PORTFOLIO
7.11.3.    KEY INNOVATION SECTOR
7.11.4.    STRATEGIC INITIATIVES
7.11.5.    SCOT ANALYSIS
7.11.6.    STRATEGIC ANALYSIS
7.12.SIEMENS AG
7.12.1.    OVERVIEW
7.12.2.    PRODUCT PORTFOLIO
7.12.3.    KEY INNOVATION SECTOR
7.12.4.    STRATEGIC INITIATIVES
7.12.5.    SCOT ANALYSIS
7.13.TERARECON INC.
7.13.1.    OVERVIEW
7.13.2.    PRODUCT PORTFOLIO
7.13.3.    KEY INNOVATION SECTOR
7.13.4.    STRATEGIC INITIATIVES
7.13.5.    SCOT ANALYSIS
7.13.6.    STRATEGIC ANALYSIS
7.14.TOSHIBA CORPORATION
7.14.1.    OVERVIEW
7.14.2.    PRODUCT PORTFOLIO
7.14.3.    KEY INNOVATION SECTOR
7.14.4.    STRATEGIC INITIATIVES
7.14.5.    SCOT ANALYSIS
7.14.6.    STRATEGIC ANALYSIS
7.15.VITAL IMAGES
7.15.1.    OVERVIEW
7.15.2.    PRODUCT PORTFOLIO
7.15.3.    KEY INNOVATION SECTOR
7.15.4.    STRATEGIC INITIATIVES
7.15.5.    SCOT ANALYSIS
7.15.6.    STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1.            GLOBAL ADVANCED VISUALIZATION MARKET BY TYPE OF PLATFORM 2014-2023 ($ MILLION)
2.            GLOBAL COMPUTED TOMOGRAPHY ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
3.            GLOBAL ULTRASOUND ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
4.            GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
5.            GLOBAL RADIOTHERAPY (RT) ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
6.            GLOBAL MAGNETIC RESONANCE IMAGING (MRI) ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
7.            GLOBAL OTHERS ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
8.            GLOBAL ADVANCED VISUALIZATION MARKET BY APPLICATION 2014-2023 ($ MILLION)
9.            GLOBAL NEUROLOGY ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
10.        GLOBAL ONCOLOGY ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
11.        GLOBAL CARDIOLOGY ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
12.        GLOBAL ORTHOPEDICS ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
13.        GLOBAL OTHER ADVANCED VISUALIZATION APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
14.        GLOBAL ADVANCED VISUALIZATION BY END USER 2014-2023 ($ MILLION)
15.        GLOBAL ACADEMIC & RESEARCH CENTERS ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
16.        GLOBAL IMAGING CENTERS ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
17.        GLOBAL HOSPITALS & SURGICAL CENTERS ADVANCED VISUALIZATION BY GEOGRAPHY 2014-2023 ($ MILLION)
18.        GLOBAL OTHER  ADVANCED VISUALIZATION END USERS BY GEOGRAPHY 2014-2023 ($ MILLION)
19.        NORTH AMERICA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
20.        EUROPE ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
21.        ASIA PACIFIC ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
22.        REST OF THE WORLD ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1.            GLOBAL ADVANCED VISUALIZATION MARKET BY COMPUTED TOMOGRAPHY 2014-2023 ($ MILLION)
2.            GLOBAL ADVANCED VISUALIZATION MARKET BY ULTRASOUND 2014-2023 ($ MILLION)
3.            GLOBAL ADVANCED VISUALIZATION MARKET BY POSITRON EMISSION TOMOGRAPHY (PET) 2014-2023 ($ MILLION)
4.            GLOBAL ADVANCED VISUALIZATION MARKET BY RADIOTHERAPY (RT) 2014-2023 ($ MILLION)
5.            GLOBAL ADVANCED VISUALIZATION MARKET BY MAGNETIC RESONANCE IMAGING (MRI) 2014-2023 ($ MILLION)
6.            GLOBAL ADVANCED VISUALIZATION MARKET BY OTHERS 2014-2023 ($ MILLION)
7.            GLOBAL ADVANCED VISUALIZATION MARKET BY NEUROLOGY 2014-2023 ($ MILLION)
8.            GLOBAL ADVANCED VISUALIZATION MARKET BY ONCOLOGY 2014-2023 ($ MILLION)
9.            GLOBAL ADVANCED VISUALIZATION MARKET BY CARDIOLOGY 2014-2023 ($ MILLION)
10.        GLOBAL ADVANCED VISUALIZATION MARKET BY ORTHOPEDICS 2014-2023 ($ MILLION)
11.        GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER APPLICATIONS 2014-2023 ($ MILLION)
12.        GLOBAL ADVANCED VISUALIZATION MARKET BY ACADEMIC & RESEARCH CENTERS 2014-2023 ($ MILLION)
13.        GLOBAL ADVANCED VISUALIZATION MARKET BY IMAGING CENTERS 2014-2023 ($ MILLION)
14.        GLOBAL ADVANCED VISUALIZATION MARKET BY HOSPITALS & SURGICAL CENTERS 2014-2023 ($ MILLION)
15.        GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER  END USERS 2014-2023 ($ MILLION)
16.        UNITED STATES (U.S.) ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
17.        CANADA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
18.        UNITED KINGDOM (UK) ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
19.        FRANCE ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
20.        GERMANY ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
21.        SPAIN ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
22.        ITALY ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
23.        ROE ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
24.        INDIA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
25.        CHINA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
26.        JAPAN ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
27.        KOREA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
28.        AUSTRALIA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
29.        ROAPAC ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
30.        LATIN AMERICA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)
31.        MENA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.